2026. METABOLIC AND CARDIOVASCULAR RISKS OF SECOND-GENERATION ANTIPSYCHOTICS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF WEIGHT GAIN, DYSLIPIDEMIA, HYPERGLYCEMIA, AND QTC PROLONGATION IN ADULTS WITH SCHIZOPHRENIA OR BIPOLAR DISORDER COMPARING OLANZAPINE, RISPERIDONE, QUETIAPINE, AND ARIPIPRAZOLE. Frontier in Medical and Health Research. 4, 3 (Mar. 2026), 599–610.